Convergent evolution of SIV env after independent inoculation of rhesus macaques with infectious proviral DNA

Virology

Volumn 312, Issue 2, 2003, Pages 470-480

  Buckley, Kathleen A ^a   Li, Pei Lin ^a,b   Khimani, Anis H ^a,b,d   Hofmann Lehmann, Regina ^a,b,e   Liska, Vladimir ^a,b,f   Anderson, Daniel C ^c   McClure, Harold M ^c   Ruprecht, Ruth M ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c EMORY UNIVERSITY   (United States)

^d F HOFFMANN LA ROCHE LTD   (Switzerland)

^e UNIVERSITY OF ZURICH   (Switzerland)

^f MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Infectious SIV DNA; Intramuscular inoculation with proviral DNA; SIV env evolution

Indexed keywords

MEASLES VACCINE; VIRUS DNA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DNA VIRUS; GENE MUTATION; GENETIC CODE; INOCULATION; MONKEY; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS MUTATION; VIRUS STRAIN;

ANIMALIA; MACACA; MACACA MULATTA; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0042062345     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0042-6822(03)00262-9     Document Type: Article

References (27)

1. Baba T.W., Jeong Y.S., Penninck D., Bronson R., Greene M.F., Ruprecht R.M. Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques. Science. 267:1995;1820-1825.
2. Baba T.W., Liska V., Khimani A.H., Ray N.B., Dailey P.J., Penninck D., Bronson R., Greene M.F., McClure H.M., Martin L.N., Ruprecht R.M. Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques. Nat. Med. 5:1999;194-203.
3. Beaumont T., van Nuenen A., Broersen S., Blattner W.A., Lukashov V.V., Schuitemaker H. Reversal of human immunodefiency virus type 1 IIIB to a neutralization-resistant phenotype in an accidentally infected laboratory worker with a progressive clinical course. J. Virol. 75:2001;2246-2252.
4. Burns D.P., Desrosiers R.C. Selection of genetic variants of simian immunodeficiency virus in persistently infected rhesus monkeys. J. Virol. 65:1991;1843-1854.
5. Choi W.S., Collignon C., Thiriart C., Burns D.P., Stott E.J., Kent K.A., Desrosiers R.C. Effects of natural sequence variation on recognition by monoclonal antibodies neutralize simian immunodeficiency virus infectivity. J. Virol. 68:1994;5395-5402.
6. Cole K.S., Alvarez M., Elliott D.H., Lam H., Martin E., Chau T., Micken K., Rowles J.L., Clements J.E., Murphey-Corb M., Montelaro R.C., Robinson J.E. Characterization of neutralization epitopes of simian immunodeficiency virus (SIV) recognized by rhesus monoclonal antibodies derived from monkeys infected with an attenuated SIV strain. Virology. 290:2001;59-73.
7. Cranage M.P., Whatmore A.M., Sharpe S.A., Cook N., Polyanskaya N., Leech S., Smith J.D., Rud E.W., Dennis M.J., Hall G.A. Macaques infected with live attenuated SIVmac are protected against superinfection via the rectal mucosa. Virology. 229:1997;143-154 doi: 10.1006/viro.2001.1144.
8. Daniel M.D., Kirchhoff F., Czajak S.C., Sehgal P.K., Desrosiers R.C. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science. 258:1992;1938-1941.
9. Gibbs J.S., Regier D.A., Desrosiers R.C. Construction and in vitro properties of SIVmac mutants with deletions in "nonessential" genes. AIDS Res. Hum. Retroviruses. 10:1994;607-616.
10. Hofmann-Lehmann R., Swenerton R.K., Liska V., Leutenegger C.M., Lutz H., McClure H.M., Ruprecht R.M. Sensitive and robust one-tube real-time reverse transcriptase-polymerase chain reaction to quantify SIV RNA load comparison of one-versus two-enzyme systems . AIDS Res. Hum. Retroviruses. 16:2000;1247-1257.
11. Hofmann-Lehmann R., Vlasak J., Chenine A.L., Li P.L., Baba T.W., Montefiori D.C., McClure H.M., Anderson D.C., Ruprecht R.M. Molecular evolution of human immunodeficiency virus env in humans and monkeys similar patterns occur during natural disease progression or rapid virus passage . J. Virol. 76:2002;5278-5284.
12. Hofmann-Lehmann R., Vlasak J., Williams A.L., Chenine A.L., McClure H.M., Anderson D.C., O'Neil S.O., Ruprecht R.M. Live attenuated, nef-deleted SIV is pathogenic in most adult macaques after prolonged observation. AIDS. 17:2003;157-166.
13. Javaherian K., Langlois A.J., Montefiori D.C., Kent K.A., Ryan K.A., Wymann P.D., Stott J., Bolognesi D.P., Murphey-Corb M., Larosa G.J. Studies of the conformation-dependent neutralizing epitopes of simian immunodeficiency virus envelope protein. J. Virol. 68:1994;2624-2631.
14. Kinsey N.E., Anderson M.G., Unangst T.J., Joag S.V., Narayan O., Zink M.C., Clements J.E. Antigenic variation of SIV mutations in V4 alter the neutralization profile . Virology. 221:1996;14-21.
15. Letvin N.L., King N.W. Immunologic and pathologic manifestations of the infection of rhesus monkeys with simian immunodeficiency virus of macaques. J. Acquir. Immune Defic. Syndr. 3:1990;1023-1040.
16. Liska V., Fultz P.N., Su L., Ruprecht R.M. Detection of simian T cell leukemia virus type I infection in seronegative macaques. AIDS Res. Hum. Retroviruses. 13:1997;1147-1153.
17. Liska V., Khimani A.H., Hofmann-Lehmann R., Fink A.N., Vlasak J., Ruprecht R.M. Viremia and AIDS in rhesus macaques after intramuscular inoculation of plasmid DNA encoding full-length SIVmac239. AIDS Res. Hum. Retroviruses. 15:1999;445-450.
18. Liska V., Lerche N.W., Ruprecht R.M. Simultaneous detection of simian retrovirus type D serotypes 1, 2, and 3 by polymerase chain reaction. AIDS Res. Hum. Retroviruses. 13:1997;433-437.
19. Liska V., Ruprecht R.M. Isolation of high-molecular-weight genomic DNA from intact biohazardous mammalian tissues. Bio-Techniques. 26:1999;62-66.
20. Marthas M.L., Sutjipto S., Higgins J., Lohman B., Torten J., Luciw P.A., Marx P.A., Pedersen N.C. Immunization with a live, attenuated simian immunodeficiency virus (SIV) prevents early disease but not infection in rhesus macaques challenged with pathogenic SIV. J. Virol. 64:1990;3694-3700.
21. Miller M.A., Murphey-Corb M., Montelaro R.C. Identification of broadly reactive continuous antigenic determinants of simian immunodeficiency virus glycoproteins. AIDS Res. Hum. Retroviruses. 8:1992;1153-1164.
22. Putkonen P., Walther L., Zhang Y.J., Li S.L., Nilsson C., Albert J., Biberfeld P., Thorstensson R., Biberfeld G. Long-term protection against SIV-induced disease in macaques vaccinated with a live attenuated HIV-2 vaccine. Nat. Med. 1:1995;914-918.
23. Ruprecht R.M. Live attenuated AIDS viruses as vaccines promise or peril? Immunol. Rev. 170:1999;135-149.
24. Torres J.V., Malley A., Banapour B., Anderson D.E., Axthelm M.K., Gardner M.B., Benjamini E. An epitope on the surface envelope glycoprotein (gp130) of simian immunodeficiency virus (SIV mac) involved in viral neutralization and T cell activation. AIDS Res. Hum. Retroviruses. 9:1993;423-440.
25. Wyand M.S., Manson K., Montefiori D.C., Lifson J.D., Johnson R.P., Desrosiers R.C. Protection by live, attenuated SIV against heterologous challenge. J. Virol. 73:1999;8356-8363.
26. Wyand M.S., Manson K.H., Garcia-Moll M., Montefiori D., Desrosiers R.C. Vaccine protection by a triple deletion mutant of simian immunodeficiency virus. J. Virol. 70:1996;3724-3733.
27. Yasutomi Y., McAdam S.N., Boyson J.E., Piekarczyk M.S., Watkins D.I., Letvin N.L. A MHC class I B locus allele-restricted simian immunodeficiency virus envelope CTL epitope in rhesus monkeys. J. Immunol. 154:1995;2516-2522.